Quibell; Martin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Quibell; Martin.The latest application filed is for "antibacterial antisense agents".
Company Profile
1.21.36
- Quibell; Martin - Biohub Alderley Park
- QUIBELL; Martin - Cambridge GB
- Quibell; Martin - Madingley GB
- Quibell; Martin - US
Patent Activity
| Patent | Date |
|---|---|
| Antibacterial Antisense Agents App 20220106595 - Quibell; Martin ; et al. | 2022-04-07 |
| Furo[3, 2-b] Pyrr0l-3-ones As Cathespin S Inhibitors App 20160361295 - QUIBELL; Martin ; et al. | 2016-12-15 |
| Furo [3, 2-b] Pyrr0l-3-0nes As Cathespin S Inhibitors App 20160015685 - Quibell; Martin ; et al. | 2016-01-21 |
| Piperazine Compounds App 20150209349 - Quibell; Martin ; et al. | 2015-07-30 |
| Furo[3, 2-b] Pyrr0l-3-ones As Cathespin S Inhibitors App 20150164912 - Quibell; Martin ; et al. | 2015-06-18 |
| Piperazine compounds Grant 9,045,492 - Quibell , et al. June 2, 2 | 2015-06-02 |
| Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors Grant 8,933,109 - Quibell , et al. January 13, 2 | 2015-01-13 |
| Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl proteinase inhibitors Grant 8,877,927 - Quibell , et al. November 4, 2 | 2014-11-04 |
| Furo[3, 2-b] Pyrr0l-3-ones As Cathespin S Inhibitors App 20140038944 - Quibell; Martin ; et al. | 2014-02-06 |
| Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors Grant 8,552,202 - Quibell , et al. October 8, 2 | 2013-10-08 |
| Compounds App 20130252969 - Quibell; Martin ; et al. | 2013-09-26 |
| Piperazine compounds Grant 8,501,744 - Quibell , et al. August 6, 2 | 2013-08-06 |
| Furo[3, 2-b] Pyrr0l-3-ones As Cathespin S Inhibitors App 20130150345 - QUIBELL; MARTIN ; et al. | 2013-06-13 |
| Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors Grant 8,389,737 - Quibell , et al. March 5, 2 | 2013-03-05 |
| Use Of Prodrugs To Avoid Gi Mediated Adverse Events App 20120202756 - Franklin; Richard ; et al. | 2012-08-09 |
| Furo[3. 2-B] pyrrol derivatives Grant 8,053,437 - Quibell , et al. November 8, 2 | 2011-11-08 |
| Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates Grant 8,039,641 - Quibell , et al. October 18, 2 | 2011-10-18 |
| Compounds Grant 8,008,290 - Quibell , et al. August 30, 2 | 2011-08-30 |
| Compounds App 20110077254 - QUIBELL; MARTIN ; et al. | 2011-03-31 |
| Compounds App 20110009385 - QUIBELL; MARTIN ; et al. | 2011-01-13 |
| Furo[3, 2-b] Pyrr0l-3-0nes As Cathespin S Inhibitors App 20110009386 - Quibell; Martin ; et al. | 2011-01-13 |
| Furo[3,2-B] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors Grant 7,846,934 - Quibell , et al. December 7, 2 | 2010-12-07 |
| Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors Grant 7,846,935 - Quibell , et al. December 7, 2 | 2010-12-07 |
| Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitors Grant 7,803,803 - Quibell , et al. September 28, 2 | 2010-09-28 |
| Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases Grant 7,799,791 - Quibell , et al. September 21, 2 | 2010-09-21 |
| Furo[3. 2-b] Pyrrol Derivatives App 20100216811 - Quibell; Martin ; et al. | 2010-08-26 |
| Furo[3, 2-b] pyrrol derivatives Grant 7,737,150 - Quibell , et al. June 15, 2 | 2010-06-15 |
| Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors App 20100010009 - Quibell; Martin ; et al. | 2010-01-14 |
| Inhibitors Of Cruzipain And Other Cysteine Proteases App 20090247471 - Quibell; Martin | 2009-10-01 |
| Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors App 20090203714 - Quibell; Martin ; et al. | 2009-08-13 |
| Tetrahdrofuro[3,2-B] pyrrol-3- one as cathepsin k inhibitors App 20090197817 - Quibell; Martin ; et al. | 2009-08-06 |
| Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors App 20090192170 - Quibell; Martin ; et al. | 2009-07-30 |
| Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates App 20090192322 - Quibell; Martin ; et al. | 2009-07-30 |
| Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases App 20090186831 - Quibell; Martin ; et al. | 2009-07-23 |
| Furo[3, 2-b] pyrrol derivatives App 20090186906 - Quibell; Martin ; et al. | 2009-07-23 |
| Biologically active compounds App 20090131502 - Quibell; Martin ; et al. | 2009-05-21 |
| Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles App 20090005575 - Quibell; Martin ; et al. | 2009-01-01 |
| Inhibitors of cruzipain and other cysteine proteases Grant 7,425,562 - Quibell September 16, 2 | 2008-09-16 |
| Method of producing conjugate vaccines App 20080213297 - Finn; Nicholas ; et al. | 2008-09-04 |
| Inhibitors of cruzipain and other cysteine proteases Grant 7,132,449 - Quibell November 7, 2 | 2006-11-07 |
| Biologically active compounds App 20060100431 - Quibell; Martin ; et al. | 2006-05-11 |
| Inhibitors of cruzipain and other cysteine proteases Grant 6,958,358 - Quibell , et al. October 25, 2 | 2005-10-25 |
| Charge-balanced chemoselective linkers App 20050158370 - Flinn, Nicholas Sean ; et al. | 2005-07-21 |
| Cysteine protease inhibitors App 20050070598 - Quibell, Martin ; et al. | 2005-03-31 |
| Cysteine protease inhibitors App 20050020588 - Quibell, Martin ; et al. | 2005-01-27 |
| Cysteine protease inhibitors App 20040229915 - Quibell, Martin ; et al. | 2004-11-18 |
| Inhibitors of cruzipain and other cysteine proteases App 20040138250 - Quibell, Martin | 2004-07-15 |
| Inhibitors of cruzipain and other cysteine proteases App 20040127424 - Quibell, Martin | 2004-07-01 |
| Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases App 20040127549 - Quibell, Martin | 2004-07-01 |
| Inhibitors of cruzipain and other cysteine proteases App 20040106805 - Quibell, Martin ; et al. | 2004-06-03 |
| Cysteine protease inhibitors App 20030203900 - Quibell, Martin ; et al. | 2003-10-30 |
| Cysteine protease inhibitors App 20030186962 - Quibell, Martin ; et al. | 2003-10-02 |
| Substrates and inhibitors of proteolytic enzymes App 20030092067 - Quibell, Martin ; et al. | 2003-05-15 |
| Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases Grant 6,034,066 - Johnson , et al. March 7, 2 | 2000-03-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 